Until now, GRP78 expression has never been explored as a predictive biomarker in multiple myeloma, although an ectopic expression of GRP78 on the cell membrane has been reported in a subgroup of MM patients [14]. The gene discussed is HSPA5; the disease is Miyoshi myopathy.